Browsing Tag
Bill Larkins
1 post
Hikma Pharmaceuticals commits to $1 billion U.S. generics expansion amid strategic reshoring efforts
Hikma Pharmaceuticals (LSE: HIK) will invest $1B in U.S. manufacturing and R&D to strengthen its position in the generics market and address domestic drug shortages.